21 Live Notices for Sirolimus Tenders
Showing 1 to 21
Delivery Of Specialist Medical Devices For The Needs Of The Hemodynamics Laboratory, Electrophysiology Laboratory And Research And Vascular Studies
12 May 2025
15 May 2025Acquisition By Compressed Medication Supply System For The Padre Alberto Hurtado Hospital
Supply of 1/ SIROLIMUS 0.5MG ORAL SOLID PREPARATION PREFERABLY TABLET. 2/ EMULSIFYING OINTMENT BP (250). 3/ BENZALKONIUM CHLORIDE 0.01% COMBINATION WITH CETRIMIDE 0.2% AS ACTIVE INGREDIENTS AS DRAPOLENE OR ITS EQUIVALENT.
Everolimus 075 Mg Cmcm Rec 1000021130
Consumables Balloon Catheters To Treat Arterial Occlusive Diseases That Have The Surface Treated With The Active Substance Sirolimus
Electronic Procedure Pursuant To Art. 50 Paragraph 1, Letter B) Of Legislative Decree 36/2023 For The Assignment Of The Supply Of Sirolimus Crema, For The Duration Of 24 Months.
Purchase Of Medically Consumable Material For Vascular Approaches For A Period Of Three Years
Medical Consumables 2
Purchase Of Drugs For The Implementation Of The Program Of Program "On Chronic Kidney Failure
Cardiological Consumables
Delivery Of Specialist Medical Devices For The Needs Of The Hemodynamics Laboratory, Electrophysiology Laboratory As Well As A Study And Vascular Research Workshop
Tender Invitation For The Supply Of Sirolimus Tablet 1Mg
Tender For Securing And Supplying Devices With Solutions And Consumables For Toxicology Laboratories Based On The Fixed Value System For Each Confirmed Result (Gpprr)
Tender For Securing And Supplying Devices With Solutions And Consumables For Toxicology Laboratories Based On The Fixed Value System For Each Confirmed Result (Gpprr)
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Sirolimus (L04Ah01) Within The Framework Of A So-Called Open-House Model.
Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Sirolimus (L04Ah01) As Part Of A So-Called Open House Model.
Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Sirolimus (L04Ah01) As Part Of A So-Called Open House Model.
Conclusion Of Non-Exclusive Discount Agreements According To § 130A Abs. 8 Sgb V For The Active Ingredient Sirolimus
Conclusion Of Non-Exclusive Discount Agreements According To § 130A Abs. 8 Sgb V For The Active Ingredient Sirolimus
Buy Sirolimus Supaflex Cruz Cylinder Stent At Ha Nam General Hospital
Tenders by Country